PHASE 2 STUDY OF PEVONEDISTAT + AZACITIDINE VERSUS AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES/CHRONIC MYELOMONOCYTIC LEUKEMIA OR LOW-BLAST ACUTE MYELOGENOUS LEUKEMIA (NCT02610777)

oleh: L. Adès, J. Watts, A. Radinoff, M.A. Sangerman, M. Cerrano, P.F. Lopez, J. Zeidner, M.D. Campelo, C. Graux, J. Liesveld, D. Selleslag, N. Tzvetkov, R.J. Fram, D. Zhao, J. Bell, S. Friedlander, D.V. Faller, M.A. Sekeres